DEIRDRE GARDNER: Open Payments
NPI 1255604849 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,158 in 121 payments from 13 companies in 2025. Trend: 2023 $1,273 · 2024 $1,257 · 2025 $2,158
Food & beverage: $2,013Education: $146
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 13 | $404 |
| Janssen Biotech, Inc. | 20 | $366 |
| ABBVIE INC. | 26 | $357 |
| Galderma Laboratories, L.P. | 31 | $304 |
| Regeneron Healthcare Solutions, Inc. | 5 | $261 |
| Novartis Pharmaceuticals Corporation | 5 | $122 |
| Lilly USA, LLC | 7 | $105 |
| Amgen Inc. | 5 | $85 |
| Arcutis Biotherapeutics, Inc. | 3 | $47 |
| Organon LLC | 3 | $42 |
Products named: DUPIXENT, TREMFYA, NEMLUVIO, RINVOQ, SKYRIZI, EBGLYSS, OTEZLA, AKLIEF.
Industry payments across PA — which companies pay providers there.
